Business Context and Reporting Period
Company: Autonomix Medical, Inc. (AMIX)
Filing Type: Form 8-K (Current Report)
Date of Report: January 14, 2026
Reporting Period: Event date January 14, 2026; Signature date January 16, 2026
Context: The Company is an emerging growth company incorporated in Delaware, with its common stock listed on The Nasdaq Capital Market.
Key Financial Metrics
This filing is a notice of a listing deficiency and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
- Stock Price Deficiency: The Company received a deficiency letter from Nasdaq stating that for the last 30 consecutive business days, the closing bid price of its common stock was below the minimum $1.00 per share requirement (Nasdaq Listing Rule 5550(a)(2)).
- Listing Status: The deficiency does not result in immediate delisting.
Guidance, Outlook, and Risks
- Compliance Period: The Company has an initial 180-calendar-day period (until July 13, 2026) to regain compliance.
- Compliance Criteria: To regain compliance, the stock must close at $1.00 or more for a minimum of 10 consecutive business days.
- Secondary Compliance Option: If not compliant by July 13, 2026, the Company may qualify for a second 180-day period if it meets other initial listing standards (e.g., market value of publicly held shares) and notifies Nasdaq of its intent to cure, potentially via a reverse stock split.
- Delisting Risk: If the Company fails to regain compliance and is ineligible for an additional period, Nasdaq may delist the stock. The Company may appeal this determination, though success is not assured.
- Management Action: The Company intends to monitor the stock price and may consider a reverse stock split to regain compliance, though there is no assurance of success.
Investor Verification Checklist
- Verify the current closing bid price of AMIX stock to assess proximity to the $1.00 threshold.
- Monitor the Company's announcements regarding the intent to implement a reverse stock split.
- Review the Company's market value of publicly held shares to determine eligibility for a second compliance period if the initial deadline is missed.
- Track the 10 consecutive business day requirement for regaining compliance before the July 13, 2026 deadline.